BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 27, 2015
 |  BioCentury  |  Finance

Athyrium doubles down

Why Athyrium thinks its $1.2B fund is in the structured finance sweet spot

Athyrium Capital Management expects its newly closed $1.2 billion fund has found the sweet spot for infusing structured capital into commercial-stage healthcare companies.

Athyrium and partner Neuberger Berman closed their first fund, Athyrium Opportunities Fund L.P., at $507 million in 2013. Although the oversubscribed new fund is more than twice as large, Athyrium's Jeffrey Ferrell said it will make a similar number of investments.

"There were 17 companies in Fund I and we'd anticipate about 20 in Fund II....

Read the full 392 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >